Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Deprez

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
European Journal of Medicinal Chemistry|February 16, 2023
Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronavirusesLucile Brier, Haitham Hassan, Xavier Hanoulle, et al.
Cell Metabolism|August 4, 2015
The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue ActivityEvie P M Broeders, Emmani B M Nascimento, Bas Havekes, et al.
European Journal of Medicinal Chemistry|July 28, 2024
N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL proteaseFatima-Zahra Chaibi, Lucile Brier, Paul Carré, et al.
Scientific Reports|May 12, 2018
Publisher Correction: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticlesJoana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny, et al.
Scientific Reports|July 16, 2017
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticlesJoana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny, et al.
European Journal of Medicinal Chemistry|December 10, 2014
Structure-activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzymeJulie Charton, Marion Gauriot, Jane Totobenazara, et al.
Journal of Medicinal Chemistry|January 20, 2021
Beyond the Rule of 5: Impact of PEGylation with Various Polymer Sizes on Pharmacokinetic Properties, Structure-Properties Relationships of mPEGylated Small Agonists of TGR5 ReceptorVanessa Hoguet, Manuel Lasalle, Mathieu Maingot, et al.
EMBO Molecular Medicine|January 4, 2024
Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniaeAnais Vieira Da Cruz, Juan-Carlos Jiménez-Castellanos, Clara Börnsen, et al.
Lancet (London, England)|November 7, 2017
Daytime variation of perioperative myocardial injury in cardiac surgery and its prevention by Rev-Erbα antagonism: a single-centre propensity-matched cohort study and a randomised studyDavid Montaigne, Xavier Marechal, Thomas Modine, et al.
Nature Communications|January 11, 2022
Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumpsColine Plé, Heng-Keat Tam, Anais Vieira Da Cruz, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Medicinal Chemistry|February 16, 2023
Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronavirusesLucile Brier, Haitham Hassan, Xavier Hanoulle, et al.
Cell Metabolism|August 4, 2015
The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue ActivityEvie P M Broeders, Emmani B M Nascimento, Bas Havekes, et al.
European Journal of Medicinal Chemistry|July 28, 2024
N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL proteaseFatima-Zahra Chaibi, Lucile Brier, Paul Carré, et al.
Scientific Reports|May 12, 2018
Publisher Correction: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticlesJoana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny, et al.
Scientific Reports|July 16, 2017
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticlesJoana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny, et al.
European Journal of Medicinal Chemistry|December 10, 2014
Structure-activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzymeJulie Charton, Marion Gauriot, Jane Totobenazara, et al.
Journal of Medicinal Chemistry|January 20, 2021
Beyond the Rule of 5: Impact of PEGylation with Various Polymer Sizes on Pharmacokinetic Properties, Structure-Properties Relationships of mPEGylated Small Agonists of TGR5 ReceptorVanessa Hoguet, Manuel Lasalle, Mathieu Maingot, et al.
EMBO Molecular Medicine|January 4, 2024
Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniaeAnais Vieira Da Cruz, Juan-Carlos Jiménez-Castellanos, Clara Börnsen, et al.
Lancet (London, England)|November 7, 2017
Daytime variation of perioperative myocardial injury in cardiac surgery and its prevention by Rev-Erbα antagonism: a single-centre propensity-matched cohort study and a randomised studyDavid Montaigne, Xavier Marechal, Thomas Modine, et al.
Nature Communications|January 11, 2022
Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumpsColine Plé, Heng-Keat Tam, Anais Vieira Da Cruz, et al.
Pageof 9